sarepta therapeutics inc
Christopher Nishan Garabedian
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2014
Mr. Christopher Nishan Garabedian, also known as Chris, had been the Chief Executive Officer and President of Sarepta Therapeutics, Inc. since January 1, 2011. Mr. Garabedian served as Vice President of Corporate Strategy at Celgene Corporation since July 2007. From November 2005 to June 2007, he served as an Independent Consultant to early-stage biopharmaceutical companies. From 1997 to November 2005, he served at Gilead Sciences, Inc., where he served in a number of ...
215 First StreetPhone: 617-274-4000
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
University of Maryland
|Ali Mortazavi||Chief Executive (leave of absence) and Director|
Silence Therapeutics plc
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Arbutus Biopharma Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|$430.0K||Compensation as of Fiscal Year 2014.|